Tilray Brands, Inc. (TSE:TLRY - Get Free Report) was down 1.6% during trading on Tuesday . The company traded as low as C$1.79 and last traded at C$1.81. Approximately 1,218,523 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 2,775,083 shares. The stock had previously closed at C$1.84.
Tilray Brands Stock Down 1.6%
The business has a fifty day moving average of C$1.95 and a 200 day moving average of C$1.25. The company has a quick ratio of 2.16, a current ratio of 2.54 and a debt-to-equity ratio of 10.76. The firm has a market cap of C$2.03 billion, a P/E ratio of -0.75 and a beta of 3.64.
About Tilray Brands
(
Get Free Report)
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
